This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Written by Dr. Parmis Mojarab, DO·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

TB-500 (thymosin beta-4 fragment): evidence, legality and safety

Quick answer

TB-500 is a synthetic version of a thymosin beta-4 fragment marketed for recovery and healing. It is NOT FDA-approved, and human clinical evidence is minimal. It is widely sold as a 'research chemical,' which is not a lawful pathway for human use.

Regulatory statusNot FDA-approved. Human evidence minimal.

What the evidence shows

Human clinical evidence

No adequate, well-controlled human trials establish efficacy or safety for the marketed uses.

Animal and laboratory evidence

Some preclinical work on tissue repair and angiogenesis exists; it does not establish human benefit. We keep animal and laboratory findings clearly separated from human evidence, because preclinical results routinely fail to translate to people.

Known and potential risks

Unapproved status, unregulated sourcing, and unknown long-term safety.

No consumer dosing for research compoundsThis page does not provide dosing instructions for unapproved compounds, and we do not link to research-chemical sellers. If you are considering peptide therapy, do it through a licensed clinician who can weigh your individual risks.

Legality and sourcing

The lawful pathway for any prescription peptide is a licensed clinician and a licensed pharmacy. Products labeled "for research use only" are not lawfully sold for human consumption. See how to verify a peptide provider and research peptides versus prescription therapy.

Status in sport

Assume prohibited; verify against the current WADA Prohibited List.

Frequently asked questions

Is TB-500 (thymosin beta-4 fragment) FDA-approved?

Not FDA-approved. Human evidence minimal.

Is there human evidence for TB-500 (thymosin beta-4 fragment)?

No adequate, well-controlled human trials establish efficacy or safety for the marketed uses.

Is TB-500 (thymosin beta-4 fragment) legal to buy?

Many peptides in this category are sold as 'research chemicals,' which is not a lawful pathway for human use. Legitimacy depends on approval status and whether a licensed clinician and pharmacy are involved. We do not link to research-chemical sellers.

Is TB-500 (thymosin beta-4 fragment) banned in sport?

Assume prohibited; verify against the current WADA Prohibited List.

Sources

U.S. Food and Drug Administration — enforcement actions and warnings on unapproved peptide products.
World Anti-Doping Agency (WADA) Prohibited List — current edition.
Peer-reviewed preclinical and (where available) clinical literature, graded for evidence quality.

Spotted an error? Submit a correction.